The Great Debate: Metabolic Surgery vs. Glucagon-Like Peptide-1 Receptor Agonists in Managing Patients with Obesity and its Related Comorbid Medical Illnesses.
Аннотация
Obesity as a chronic disease continues to increase in prevalence despite continual advancements in surgical and medical therapy. Bariatric surgery has been the gold-standard for effective treatment of obesity and its related diseases for multiple decades. However, with the continual introduction of newer and more effective glucagon-like peptide one receptor agonists, the most effective non-surgical therapy to date, the debate has begun about which therapy is more effective in treating patients suffering from chronic obesity. As data continues to emerge, further consideration must be given regarding the use of these modalities as monotherapy or as combination therapy for treating obesity. We will provide arguments for each therapy and make a further argument for multimodal therapy to treat the challenging disease of obesity.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.